Publications:

Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.

Cell Death & Disease

Scherr, Anna-Lena AL; Mock, Andreas A; Gdynia, Georg G; Schmitt, Nathalie N; Heilig, Christoph E CE; Korell, Felix F; Rhadakrishnan, Praveen P; Hoffmeister, Paula P; Metzeler, Klaus H KH; Schulze-Osthoff, Klaus K; Illert, Anna L AL; Boerries, Melanie M; Trojan, Jörg J; Waidmann, Oliver O; Falkenhorst, Johanna J; Siveke, Jens J; Jost, Philipp J PJ; Bitzer, Michael M; Malek, Nisar P NP; Vecchione, Loredana L; Jelas, Ivan I; Brors, Benedikt B; Glimm, Hanno H; Stenzinger, Albrecht A; Grekova, Svetlana P SP; Gehrig, Tobias T; Schulze-Bergkamen, Henning H; Jäger, Dirk D; Schirmacher, Peter P; Heikenwalder, Mathias M; Goeppert, Benjamin B; Schneider, Martin M; Fröhling, Stefan S; Köhler, Bruno C BC

Publication Date: 2020-10-17

Variant appearance in text: EGFR: A17F

PubMed Link: 33070156

Variant Present in the following documents:

• Main text

View BVdb publication page

Clinical development of CAR T cell therapy in China: 2020 update.

Cellular & Molecular Immunology

Wei, Jianshu J; Guo, Yelei Y; Wang, Yao Y; Wu, Zhiqiang Z; Bo, Jian J; Zhang, Bin B; Zhu, Jun J; Han, Weidong W

Publication Date: 2021-04

Variant appearance in text: EGFR: A17F

PubMed Link: 32999455

Variant Present in the following documents:

• Main text

View BVdb publication page